FDA Drug Recalls

Recalls / Class II

Class IID-0379-2017

Product

Mitomycin 20 mg Injectable, Lyophilized (Buffered), 1 mL vial, Kit, Compounded by Wells Pharmacy, Ocala, FL

Affected lot / code info
All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. Known kit lot code: 05122016@84, 07012016@107. Known vial lot code: 04212016@149, 06082016@7.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Wells Pharmacy Network LLC
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
1210 SW 33rd Ave, N/A, Ocala, Florida 34474-2853

Distribution

Quantity
315 kits (number of vials per kit vary by prescription)
Distribution pattern
Nationwide

Timeline

Recall initiated
2016-09-21
FDA classified
2017-01-04
Posted by FDA
2017-01-11
Terminated
2021-07-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0379-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls